PE(12:1e/22:0)
lipidPhosphatidylethanolamine plasmalogen dysregulated in myocardial injury and post-MI heart failure.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencelow
RationalePlasmalogens dysregulated in myocardial injury; predictor of post-MI heart failure.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only
Literature evidence(1)
- Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure.Lipids in health and disease · 2023 · PMID 37210547 · doi